75 related articles for article (PubMed ID: 23489282)
1. Safety and feasibiLIty of Metformin in patients with Impaired glucose Tolerance and a recent TIA or minor ischemic stroke (LIMIT) trial - a multicenter, randomized, open-label phase II trial.
den Hertog HM; Vermeer SE; Zandbergen AA; Achterberg S; Dippel DW; Algra A; Kappelle LJ; Koudstaal PJ
Int J Stroke; 2015 Jan; 10(1):105-9. PubMed ID: 23489282
[TBL] [Abstract][Full Text] [Related]
2. Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial.
Osei E; Fonville S; Zandbergen AA; Brouwers PJ; Mulder LJ; Lingsma HF; Dippel DW; Koudstaal PJ; den Hertog HM
Trials; 2015 Aug; 16():332. PubMed ID: 26242578
[TBL] [Abstract][Full Text] [Related]
3. Safety, feasibility and efficacy of metformin and sitagliptin in patients with a TIA or minor ischaemic stroke and impaired glucose tolerance.
Osei E; Zandbergen A; Brouwers PJAM; Mulder LJMM; Koudstaal P; Lingsma H; Dippel DWJ; den Hertog H
BMJ Open; 2021 Sep; 11(9):e046113. PubMed ID: 34531203
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke.
Kernan WN; Inzucchi SE; Viscoli CM; Brass LM; Bravata DM; Shulman GI; McVeety JC; Horwitz RI
Stroke; 2003 Jun; 34(6):1431-6. PubMed ID: 12730556
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and predictors of persistent impaired glucose tolerance after acute ischemic stroke or transient ischemic attack.
Fonville S; den Hertog HM; Zandbergen AA; Koudstaal PJ; Lingsma HF
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1669-75. PubMed ID: 24725814
[TBL] [Abstract][Full Text] [Related]
6. Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke.
Vermeer SE; Sandee W; Algra A; Koudstaal PJ; Kappelle LJ; Dippel DW;
Stroke; 2006 Jun; 37(6):1413-7. PubMed ID: 16627787
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.
Kernan WN; Viscoli CM; Inzucchi SE; Brass LM; Bravata DM; Shulman GI; McVeety JC
Arch Intern Med; 2005 Jan; 165(2):227-33. PubMed ID: 15668371
[TBL] [Abstract][Full Text] [Related]
8. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Chazova I; Almazov VA; Shlyakhto E
Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
[TBL] [Abstract][Full Text] [Related]
9. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
[TBL] [Abstract][Full Text] [Related]
10. Safety and feasibility of post-stroke care and exercise after minor ischemic stroke or transient ischemic attack: MotiveS & MoveIT.
Boss HM; Van Schaik SM; Deijle IA; de Melker EC; van den Berg BT; Scherder EJ; Bosboom WM; Weinstein HC; Van den Berg-Vos RM
NeuroRehabilitation; 2014; 34(3):401-7. PubMed ID: 24473242
[TBL] [Abstract][Full Text] [Related]
11. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
Dengler R; Diener HC; Schwartz A; Grond M; Schumacher H; Machnig T; Eschenfelder CC; Leonard J; Weissenborn K; Kastrup A; Haberl R;
Lancet Neurol; 2010 Feb; 9(2):159-66. PubMed ID: 20060783
[TBL] [Abstract][Full Text] [Related]
12. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
Rouhl RP; Lodder J
Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
[TBL] [Abstract][Full Text] [Related]
13. Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA.
Lundström A; Laska AC; Von Arbin M; Jörneskog G; Wallén H
Platelets; 2014; 25(2):102-10. PubMed ID: 23527528
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naïve patients with type 2 diabetes.
Horton ES; Foley JE; Shen SG; Baron MA
Curr Med Res Opin; 2004 Jun; 20(6):883-9. PubMed ID: 15200747
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Persistent Impaired Glucose Tolerance in Patients with Minor Ischemic Stroke or Transient Ischemic Attack.
Osei E; den Hertog HM; Fonville S; Brouwers PJAM; Mulder LJMM; Koudstaal PJ; Dippel DWJ; Zandbergen AAM; Lingsma HF
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104815. PubMed ID: 32303400
[TBL] [Abstract][Full Text] [Related]
16. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial.
Diener HC; Eikelboom J; Connolly SJ; Joyner CD; Hart RG; Lip GY; O'Donnell M; Hohnloser SH; Hankey GJ; Shestakovska O; Yusuf S;
Lancet Neurol; 2012 Mar; 11(3):225-31. PubMed ID: 22305462
[TBL] [Abstract][Full Text] [Related]
17. Is isolated aphasia a typical presentation of presumed cardioembolic transient ischemic attack or stroke?
Fennis TF; Compter A; van den Broek MW; Koudstaal PJ; Algra A; Koehler PJ
Cerebrovasc Dis; 2013; 35(4):337-40. PubMed ID: 23615539
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial.
Pratley RE; Nauck M; Bailey T; Montanya E; Cuddihy R; Filetti S; Thomsen AB; Søndergaard RE; Davies M;
Lancet; 2010 Apr; 375(9724):1447-56. PubMed ID: 20417856
[TBL] [Abstract][Full Text] [Related]
19. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials.
Li X; Zhou G; Zhou X; Zhou S
J Neurol Sci; 2013 Sep; 332(1-2):92-6. PubMed ID: 23871093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
